Liquidia Corp (LQDA)
10.15
+0.03
(+0.30%)
USD |
NASDAQ |
Nov 21, 16:00
10.16
+0.01
(+0.10%)
After-Hours: 20:00
Liquidia Enterprise Value: 654.69M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 654.69M |
| November 20, 2024 | 652.15M |
| November 19, 2024 | 655.54M |
| November 18, 2024 | 626.76M |
| November 15, 2024 | 628.46M |
| November 14, 2024 | 644.11M |
| November 13, 2024 | 664.85M |
| November 12, 2024 | 695.32M |
| November 11, 2024 | 703.78M |
| November 08, 2024 | 729.17M |
| November 07, 2024 | 712.25M |
| November 06, 2024 | 696.17M |
| November 05, 2024 | 678.39M |
| November 04, 2024 | 680.93M |
| November 01, 2024 | 724.94M |
| October 31, 2024 | 713.94M |
| October 30, 2024 | 727.48M |
| October 29, 2024 | 729.01M |
| October 28, 2024 | 728.17M |
| October 25, 2024 | 726.48M |
| October 24, 2024 | 729.86M |
| October 23, 2024 | 732.40M |
| October 22, 2024 | 742.54M |
| October 21, 2024 | 733.24M |
| October 18, 2024 | 737.47M |
| Date | Value |
|---|---|
| October 17, 2024 | 764.52M |
| October 16, 2024 | 778.90M |
| October 15, 2024 | 757.76M |
| October 14, 2024 | 737.04M |
| October 11, 2024 | 732.82M |
| October 10, 2024 | 729.01M |
| October 09, 2024 | 734.09M |
| October 08, 2024 | 727.32M |
| October 07, 2024 | 738.31M |
| October 04, 2024 | 643.62M |
| October 03, 2024 | 648.70M |
| October 02, 2024 | 641.51M |
| October 01, 2024 | 659.69M |
| September 30, 2024 | 641.09M |
| September 27, 2024 | 711.53M |
| September 26, 2024 | 722.50M |
| September 25, 2024 | 736.84M |
| September 24, 2024 | 720.81M |
| September 23, 2024 | 704.78M |
| September 20, 2024 | 706.47M |
| September 19, 2024 | 733.47M |
| September 18, 2024 | 703.09M |
| September 17, 2024 | 692.12M |
| September 16, 2024 | 710.69M |
| September 13, 2024 | 693.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.83M
Minimum
Dec 19 2019
1.188B
Maximum
Mar 22 2024
331.29M
Average
264.10M
Median
May 23 2022
Enterprise Value Benchmarks
| United Therapeutics Corp | 13.47B |
| Arcturus Therapeutics Holdings Inc | 225.20M |
| Paragon 28 Inc | 944.68M |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| AIM ImmunoTech Inc | 9.017M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.16M |
| Revenue (Quarterly) | 4.448M |
| Total Expenses (Quarterly) | 33.64M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 64.82% |
| Profit Margin (Quarterly) | -520.6% |
| Earnings Yield | -16.06% |
| Normalized Earnings Yield | -15.47 |